反向收购实操范本：中企借OTC市场实现赴美上市

Core Viewpoint - The increasing listing thresholds on NASDAQ and NYSE have created challenges for Chinese companies seeking to raise funds abroad, yet a private high-tech company has successfully entered the international capital market through a precise strategy [1]. Group 1: Company Overview - Yichang Keli Sheng Industrial Group Co., Ltd. has successfully achieved a U.S. listing by acquiring the OTC-listed company Blue Star Global Inc. [1]. - Keli Sheng Group has over 20 years of investment in new materials, focusing on high-temperature materials that provide advanced solutions for industries such as silicon steel, photovoltaics, new energy vehicles, aerospace, and nuclear power [3]. Group 2: Innovative Pathway to Listing - The successful U.S. listing of Keli Sheng Group exemplifies an innovative approach involving "acquisition of an OTC-listed company + asset injection + transfer to NASDAQ + refinancing," serving as a valuable reference for many domestic SMEs [3]. - Compared to traditional IPOs, which can take 12-24 months and involve high compliance costs, acquiring an OTC shell allows companies to gain listing status in a much shorter time frame [5]. Group 3: OTC Market Insights - The U.S. OTC market is a crucial part of the multi-tiered capital market, providing a flexible and mature mechanism for international SMEs like Keli Sheng, acting as a "golden springboard" for entering the U.S. capital market [5]. - The OTC market has hosted numerous multinational giants, indicating its potential for smaller companies to establish a foothold in the U.S. [5]. Group 4: Strategic Recommendations for Chinese SMEs - Chinese SMEs aiming for U.S. listings can follow a "precise selection of pathways and steady upgrades" strategy, starting with the OTC Pink tier for startups and progressing to OTCQB or OTCQX for more mature companies [6]. - The reverse acquisition (backdoor listing) is recommended for companies with limited funds and urgent listing needs, as it allows for immediate capital operation without the barriers of a direct IPO [6]. - Companies should ensure compliance by standardizing financial reports according to U.S. GAAP/IFRS and preparing for dual regulatory requirements to facilitate future transfers and financing [6]. - The OTC market serves as a training ground for compliance, allowing companies to meet necessary metrics before applying for a transfer to NASDAQ or NYSE [6].